BI-7273

CAS No. 1883429-21-7

BI-7273 ( BI7273;BI 7273 )

Catalog No. M12926 CAS No. 1883429-21-7

A potent, selective and cell-permeable BRD9 bromodomain inhibitor with IC50 of 19 nM in Alpha assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 58 In Stock
5MG 87 In Stock
10MG 168 In Stock
25MG 339 In Stock
50MG 537 In Stock
100MG 764 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BI-7273
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective and cell-permeable BRD9 bromodomain inhibitor with IC50 of 19 nM in Alpha assay.
  • Description
    A potent, selective and cell-permeable BRD9 bromodomain inhibitor with IC50 of 19 nM in Alpha assay; displays >5-fold selectiveity over BRD7, and >5,000-fold over BRD4-BD1, BRD4-BD2, and BRD2-BD1; blocks EOL-1 cell proliferation with EC50 of 1.4 uM, and displays antitumor activity in an AML xenograft model.
  • Synonyms
    BI7273;BI 7273
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    BRD7;BRD9
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1883429-21-7
  • Formula Weight
    353.41
  • Molecular Formula
    C20H23N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mg/mL
  • SMILES
    O=C1N(C)C=C(C2=CC(OC)=C(CN(C)C)C(OC)=C2)C3=CC=NC=C13
  • Chemical Name
    2,7-Naphthyridin-1(2H)-one, 4-[4-[(dimethylamino)methyl]-3,5-dimethoxyphenyl]-2-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Martin LJ, et al. J Med Chem. 2016 May 26;59(10):4462-75.
molnova catalog
related products
  • CN427

    CN427 (CN-427) is novel BRD4 (BD1, 2) inhibitor with IC50 of 66 nM, MV4-11 viability IC50 of 1.1 uM.

  • GW 841819X

    GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain.

  • CBP bromodomain inhi...

    a potent, selective CBP bromodomain inhibitor with IC50 of 69 nM, displays exquisite selectivity over BRD4(1) (IC50=18 uM) and the broader bromodomain family.